Thursday, November 14, 2019 5:09:21 PM
I feel that the company may be legit, but the lack of acceptance of cannabis may be working against them so much that they simply can't overcome it. Certainly they may get support in Israel, but that can only get them inexpensive Phase 1 and maybe small Phase 2 Trials done cheaply, but international Phase 3 are a very different matter, and if you cannot get the patent approval for what you're testing, no one is going to fund such an effort.
I understand your feeling about the money, but the same can be said for practically any struggling company, but executives still get certain perks, and I cannot begrudge them that.
If they gain one multi-national patent for a major product everything could change. I believe it's clear they'll need a partner to fully develop anything, but with patent approval and a Phase 1 and perhaps a small Phase 2 demonstrating efficacy, a partner would certainly be possible. What's needed is the patent and while the company may be fighting for them, they're not communicating what they're doing to investors.
Gary
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM